Five things for pharma marketers to know: Thursday, September 24, 2020
U.S. health officials testify before Congress; J&J begins late-stage vaccine trial; AstraZeneca’s COVID-19 vaccine trial remains under investigation by FDA.
Coronavirus
Coronavirus Briefing: 200,000 dead in the U.S., Halloween guidelines, the ‘Class of COVID-19’
This week’s Haymarket Media Coronavirus Briefing is 1,495 words and will take you seven minutes to read.
What happened when an influencer-led COVID-19 safety campaign in Texas ran into challenges
The Texas Department of State Health Services shared how it turned the campaign into a success.
Five things for pharma marketers to know: Wednesday, September 23, 2020
FDA to issue guidance outlining tougher standards for a COVID-19 vaccine; Biden campaign balances criticizing Trump’s vaccine efforts with encouraging trust in vaccines; U.S. surpasses 200,000 deaths from coronavirus.
Five things for pharma marketers to know: Tuesday, September 22, 2020
CDC reverses stance on airborne transmission of COVID-19; Group of Black doctors to independently vet COVID-19 decisions; Join the virtual MM+M Hall of Femme today.
Campaign: Blood Equality effort expands to include COVID-19 antibody donation
The Blood Equality campaign, created by GMHC and FCB Health New York, advocates to reverse the ban on gay and bisexual men donating blood.
Twitter launches an OOH campaign to combat mask-fatigue
Major market crossroads, including Times Square in NYC and Millennium Park in Chicago, will be plastered with billboards of Tweets that make light of mask life.
‘America has no one left to trust:’ Former HHS comms staffers on COVID-19 report meddling
“You don’t renegotiate a bible when you teach it,” says one ex-HHS official.
Five things for pharma marketers to know: Friday, September 18, 2020
Moderna expects to know if COVID-19 vaccine is safe by Nov.; NY files opioid lawsuit against J&J; #WhoSavesTheirLives: An initiative advocating better support for HCPs.
Five things for pharma marketers to know: Thursday, September 17, 2020
U.S. plans to distribute vaccine within 24 hours of approval; CDC needs $6B to distribute a potential vaccine nationwide; Eli Lilly’s antibody helped reduce hospitalization for coronavirus patients.
